33.3 Introduction to the Urinary System

Anatomy and Physiology of the Urinary System

The urinary system filters waste from the blood, maintains fluid and electrolyte balance, and eliminates urine from the body. For nursing pharmacology, understanding this system's anatomy and physiology is essential because so many drugs act directly on these structures, particularly the kidneys, to produce their therapeutic effects.

Urinary System Components

Kidneys

The kidneys are bean-shaped organs located in the retroperitoneal space (behind the peritoneum, against the posterior abdominal wall). They perform three core functions:

• Filtering blood to remove waste products and excess fluid
• Regulating electrolytes (sodium, potassium, calcium) and acid-base balance
• Producing urine (typically 1–2 liters per day in a healthy adult)

The kidneys also have endocrine functions you'll encounter in pharmacology, including producing erythropoietin (stimulates red blood cell production) and activating vitamin D.

Ureters

The ureters are thin, muscular tubes about 10–12 inches long that connect each kidney to the bladder. They transport urine from the renal pelvis to the bladder through peristaltic contractions, which are rhythmic waves of smooth muscle contraction that propel urine downward. Gravity helps, but peristalsis is the primary mechanism, which is why urine can still reach the bladder even when you're lying down.

Bladder

The bladder is a hollow, muscular organ in the pelvic cavity that stores urine until it's ready to be expelled. Key structures include:

• Detrusor muscle: The smooth muscle wall of the bladder that contracts during urination to push urine out
• Trigone: A triangular region on the interior floor of the bladder, formed by the openings of the two ureters and the urethra. This area is clinically significant because it's a common site for infections to persist.

A normal bladder holds about 300–600 mL of urine, though the urge to void typically begins around 200–300 mL.

Urethra

The urethra is a thin tube that carries urine from the bladder to the outside of the body. A key anatomical difference between sexes matters clinically:

• Female urethra: approximately 1.5 inches long
• Male urethra: approximately 8 inches long (passes through the prostate gland and the length of the penis)

The shorter female urethra is a major reason why women are more susceptible to urinary tract infections, since bacteria have a much shorter distance to travel to reach the bladder.

Micturition Process

Micturition (urination) is the process of emptying the bladder. It involves both involuntary reflexes and voluntary control, which is why you can sense a full bladder but choose to delay urination.

The process unfolds in three stages:

1. Filling stage: Urine drains into the bladder from the ureters. The detrusor muscle relaxes and stretches to accommodate increasing volume without a significant rise in pressure.
2. Storage stage: The internal urethral sphincter (involuntary smooth muscle) and the external urethral sphincter (voluntary skeletal muscle) both remain contracted, preventing leakage.
3. Emptying stage: Once the bladder reaches its threshold volume (about 300–400 mL), stretch receptors in the bladder wall fire sensory signals to the sacral spinal cord (S2–S4). This triggers the micturition reflex: motor neurons stimulate the detrusor muscle to contract and the internal sphincter to relax. The pontine micturition center in the brainstem coordinates the voluntary decision to void by signaling the external urethral sphincter to relax, allowing urine to flow through the urethra.

Common Urinary System Disorders

These disorders come up frequently in pharmacology because each one has drug therapies you'll need to understand. Knowing the underlying pathophysiology helps you anticipate why specific medications are prescribed.

Urinary Incontinence

Urinary incontinence is the involuntary loss of urine. There are several types, and the distinction matters because treatment differs for each:

• Stress incontinence: Urine leaks during activities that increase abdominal pressure, such as coughing, sneezing, laughing, or lifting. The underlying problem is typically weakened pelvic floor muscles or a weakened urethral sphincter.
• Urge incontinence: A sudden, intense urge to urinate followed by involuntary urine loss. This is often associated with overactive bladder, where the detrusor muscle contracts involuntarily. Anticholinergic medications are commonly used here to reduce these contractions.
• Overflow incontinence: The bladder doesn't empty completely, becomes overfilled, and urine leaks out. Causes include bladder outlet obstruction (such as an enlarged prostate) or a weak detrusor muscle that can't generate enough force to empty.
• Mixed incontinence: A combination of stress and urge incontinence symptoms occurring together.

Urinary Tract Infections (UTIs)

UTIs are among the most common infections you'll encounter in clinical practice. They're classified by location:

Cystitis is infection of the bladder, most commonly caused by Escherichia coli (E. coli) bacteria ascending from the urethra. Symptoms include:

• Dysuria (painful or burning urination)
• Urinary frequency and urgency
• Suprapubic pain
• Hematuria (blood in urine)

Pyelonephritis is infection of the kidney, which can develop when cystitis is left untreated and bacteria ascend through the ureters. This is a more serious condition with systemic symptoms:

• Fever and chills
• Flank pain (costovertebral angle tenderness)
• Nausea and vomiting

Risk factors for UTIs include female anatomy (short urethra), sexual activity, poor perineal hygiene, urinary catheterization, and urinary stasis (incomplete bladder emptying, which allows bacteria to multiply in residual urine).

Benign Prostatic Hyperplasia (BPH)

BPH is a noncancerous enlargement of the prostate gland that commonly affects men over age 50. Because the prostate surrounds the proximal urethra, enlargement compresses the urethra and obstructs urine flow. Symptoms include:

• Urinary frequency and urgency (especially nocturia, or waking at night to urinate)
• Weak urine stream and hesitancy
• Incomplete bladder emptying
• Post-void dribbling

BPH is a major pharmacology topic because two main drug classes target it: alpha-1 adrenergic blockers (which relax smooth muscle in the prostate and bladder neck) and 5-alpha reductase inhibitors (which shrink the prostate over time by blocking testosterone conversion).